期刊文献+

三氧化二砷对MRL-lpr狼疮肾炎小鼠淋巴细胞凋亡及相关基因的影响

Effects of arsenic trioxide on lymphocyte apoptosis and its related genes in MRL-lpr mice with lupus nephritis
下载PDF
导出
摘要 目的通过检测淋巴细胞凋亡比例、凋亡相关基因表达的变化情况,探讨三氧化二砷对MRL-lpr狼疮肾炎小鼠淋巴细胞凋亡的影响。方法14只MRL-lpr小鼠,随机分为两组,实验组用三氧化二砷隔日腹腔注射,对照组用生理盐水,疗程结束后检测两组小鼠抗双链DNA抗体水平、用流式细胞仪检测两组小鼠脾脏淋巴细胞凋亡情况、逆转录-聚合酶链反应检测基因caspase-3的表达水平及蛋白印记法测bcl-2的蛋白表达。结果实验组抗双链DNA抗体水平显著低于对照组,脾脏淋巴细胞凋亡较对照组明显增多,caspase-3水平亦明显增高,而bcl-2表达减少。结论三氧化二砷能够诱导MRL-lpr狼疮肾炎小鼠自身反应性淋巴细胞发生凋亡,其作用机制可能与激活caspase家族成员、抑制bcl-2等自身基因表达有关。 Objective To investigate the effects of arsenic trioxide on lymphocyte apoptosis in MRL-lpr mice with lupus nephritis, through the observation of apoptotic lymphocytes and gene expression relating to apoptosis. Methods Fourteen MRL-lpr mice were randomly assigned into experimental group or control group. Mice in experimental group were treated with arsenic trioxide and those in control group with saline. Mouse anti-dsDNA antibody titer was detected by ELISA. Apoptotic lymphocytes in spleen were assessed by flow cytometry. Caspase-3 expression was measured by RT-PCR, and bcl-2 expression by western blot. Results Anti-dsDNA antibody titer was significantly lower in experimental group than in control group. More apoptotic cells were found in spleen from mice of experimental group. Caspase-3 RNA was significantly higher in experimental group than in control group, but bcl-2 protein was less in experimental group. Conclusion Arsenic trioxide induces apoptosis of autoimmune lymphocytes in MRL- lpr mice with lupus nephritis, probably through the activation of caspase family and the inhibition of bcl-2 expression.
出处 《中国血液净化》 2009年第4期206-210,共5页 Chinese Journal of Blood Purification
基金 黑龙江省教育厅基金资助项目(11521084) 黑龙江省卫生厅基金资助项目(2005-148) 哈尔滨医科大学附属第一临床医学院青年基金(2007103)
关键词 三氧化二砷 凋亡 CASPASE-3 Bcl-2 Arsenic trioxide Apoptosis Caspase-3 Bcl-2
  • 相关文献

参考文献20

  • 1Fournie G. Cell death and lupus[J]. Ann Med Interne Paris, 1996,147:472-479.
  • 2Bidere N, Su HC, Lenardo MJ. Genetic disorders of programmed cell death in the immune system[J]. Annu Rev Immunol, 2006,24: 321-352.
  • 3Lenardo M, Chan KM, Hornung F, et al. Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic enviroament[J]. Annu Rev Immunol, 1999, 17: 221-253.
  • 4Krueger A, Fas SC, Baumann S, et al. The role of CD95 in the regulation of peripheral T-cell apoptosis[J]. Immunol Rev, 2003,193: 58-69.
  • 5万柯,温黎青.免疫吸附疗法在系统性红斑狼疮中的临床应用[J].中国血液净化,2008,7(7):383-385. 被引量:2
  • 6Bobe P, Bonardelle D, Benihoud K, et al. Arsenic trioxide:a promising novel therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL/lpr mice[J]. Blood, 2006, 108:3967-3975.
  • 7Jip Y, Chen G, Huang X. Arsentic trioxide induces multiple myekma the cell apoptosis via disruption of mitochondrial transmembrane potentials and activation of caspase-3 [J]. Chin Med J Eng, 2001,114:19-28.
  • 8Pu YS, Hour TC, Chen J. hrsentic trioxide as a novel anti cancer agent against human transitional carcinoma-characterizing its apoptatic- pathway[J]. Anticancer Drugs, 2002, 13:293-307.
  • 9Nakagawa Y, Akao Y, Morikawa H. Arsentic trioxide-induced apoptosis through oxidative stress in cells of colon can cer cell lines[J]. Li-fe Sci, 2002,70:2253-2268.
  • 10Zhu J, Okumura H, Ohtakes. Arsentic trioxide induces apoptesis in leukemia lympho cell lines via the CD95, CD95L system[J]. Oncol Rep, 2003,10:705-719.

二级参考文献16

  • 1张静波,张耀全,刘敏,杨惠标,黄唯麟,梁莉,郭晓霞,王代红,郭艳红,陈枫,黄拥军.DNA免疫吸附治疗狼疮性肾炎的临床观察[J].中国血液净化,2006,5(1):27-29. 被引量:29
  • 2M. Belak, H. Borberg, C. Jimenez, et al. The technology and clinical experiences of the protein A immunoadsorption [J].Transfus. sci, 1994,15:419.
  • 3Yang Y, Yu YT, Song JC, et al. A new DNA immune adsorbent for hemoperfusion in SLE therapy: a clinical trial[J].Artif Organs, 1988,12:444-446.
  • 4Gao CL, Li BA, Chen CZ, et al. Clinical trial of immunoadsorbent in systemic lupus erythematosus therapy[J]. Artif Organs, 1995,19:468-469.
  • 5Gaubitz M, Seidel M, Kummer S, et al. Prospective randomized trial of two different immunoadsorbers in severe systemic erythematosus[J]. Journal of Autoimmunity, 1998, 11:495-501.
  • 6Graninger Monika, Schmaldienst Sabine, Derfler K, et al. Immunoadsorption therapy (therasorb) in patients with severe lupus erythmatosus[J]. Acta Medica Austriaca, 2002, 29:26-29.
  • 7Stummvoll GH, Aringer M, Smolen JS, et al. IgG immunoadsorption reduces systemic lupus erythematosus activity and proteinuria: a long term observational study[J]. Annals of the Rheumatic Diseases, 2005,64:1015-1021.
  • 8Pfueller B, Wolbart K, Bruns A, et al. Successful treatment of patients with systemic lupus erythematosus by immunoadsorption with a Clq column: a pilot study[J]. Arthritis and Rheumatism, 2001, 44:1962-1963.
  • 9Braun N, Erley C, Klein R, et al. Immunoadsorption onto protein A induces remission in severe systemic lupus erythematosus[J]. Nephrol Dial Transplant, 2000,15:1367- 1372.
  • 10Griveas I, Sourgounis A, Visvardis G, et al. Immunoadsorption in lupus myocarditis[J].Ther Apher Dial, 2004,8:281-285.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部